43769 recent Wall Street rating changes — with our own star rating shown next to every analyst we independently track.
Track the latest analyst rating changes from Wall Street brokerages: stock upgrades, downgrades and price-target revisions, updated through the day. Unlike a plain ratings feed, every change here is matched — where we can — to the analyst's independent track record on 13Foresight, so you can see at a glance whether the person behind the call has actually been accurate. Analysts we rank show a ★★★★☆ score and link to their full performance page; firms link to their pooled track record. Use the tabs below to filter by change type.
| When | Stock | Change | Analyst | Rating | Price Target |
|---|---|---|---|---|---|
|
Aug 12
18:17 UTC
|
RDCM
Radcom
|
◎ Target | Ryan Koontz ★★★☆☆ #1769 | Buy | $18.00→ $14.00-22.2% |
|
Aug 12
18:17 UTC
|
RAPP
Rapport Therapeutics
|
◎ Target | Douglas Tsao ★★☆☆☆ #2352 | Buy | $40.00→ $66.00+65.0% |
|
Aug 12
18:17 UTC
|
KNTK
Kinetik
|
◎ Target | Gabe Daoud not yet tracked | Buy | $53.00→ $59.00+11.3% |
|
Aug 12
18:17 UTC
|
JRVR
James River Group
|
◎ Target | Mark Hughes ★★★☆☆ #1308 | Hold | $6.00→ $5.00-16.7% |
|
Aug 12
18:17 UTC
|
IMNM
Immunome
|
◎ Target | Supawat Thongthip not yet tracked | Buy | $37.00→ $38.00+2.7% |
|
Aug 12
18:17 UTC
|
EVH
Evolent Health
|
◎ Target | Jailendra Singh ★★★☆☆ #1490 | Hold | $7.00→ $6.00-14.3% |
|
Aug 12
18:17 UTC
|
ET
Energy Transfer
|
◎ Target | Gabe Daoud not yet tracked | Buy | $23.00→ $25.00+8.7% |
|
Aug 12
18:17 UTC
|
DEC
Diversified Energy
|
◎ Target | Gabe Daoud not yet tracked | Buy | $17.00→ $20.00+17.6% |
|
Aug 12
18:17 UTC
|
CRWV
CoreWeave
|
◎ Target | Arvind Ramnani ★★☆☆☆ #2836 | Buy | $126.00→ $155.00+23.0% |
|
Aug 12
18:17 UTC
|
CCJ
Cameco
|
◎ Target | Christopher Souther not yet tracked | Buy | $129.00→ $130.00+0.8% |
|
Aug 12
18:17 UTC
|
BWAY
Brainsway
|
◎ Target | Sam Eiber ★★★☆☆ #2200 | Buy | $18.00→ $20.00+11.1% |
|
Aug 12
18:17 UTC
|
BHST
BioHarvest Sciences
|
◎ Target | Sean McGowan ★★☆☆☆ #2771 | Buy | $10.00→ $8.00-20.0% |
|
Aug 12
18:17 UTC
|
BBIO
BridgeBio Pharma
|
◎ Target | Danielle Brill ★★☆☆☆ #2280 | Buy | $102.00→ $107.00+4.9% |
|
Aug 12
17:17 UTC
|
ZURA
Zura Bio
|
◎ Target | Martin Fan ★★★★☆ #878 | Outperform | $15.00→ $22.00+46.7% |
|
Aug 12
17:17 UTC
|
USFD
US Foods
|
◎ Target | Brian Mullan ★★★★★ #111 | Neutral | $88.00→ $108.00+22.7% |
|
Aug 12
17:17 UTC
|
UPWK
Upwork
|
◎ Target | Maria Ripps ★★★★☆ #531 | Hold | $10.00→ $9.00-10.0% |
|
Aug 12
17:17 UTC
|
TXG
10x Genomics
|
◎ Target | Mason Carrico ★★★☆☆ #2255 | Overweight | $50.00→ $65.00+30.0% |
|
Aug 12
17:17 UTC
|
TWFG
TWFG
|
◎ Target | Tommy McJoynt not yet tracked | Market Perform | $26.00→ $29.00+11.5% |
|
Aug 12
17:17 UTC
|
RPD
Rapid7
|
◎ Target | Anne Meisner not yet tracked | Neutral | $7.00→ $15.00+114.3% |
|
Aug 12
17:17 UTC
|
ONIT
Onity Group
|
◎ Target | Bose George ★★★☆☆ #2164 | Outperform | $58.00→ $55.00-5.2% |
|
Aug 12
17:17 UTC
|
NTRA
Natera
|
◎ Target | David Westenberg ★★★★☆ #583 | Overweight | $249.00→ $363.50+46.0% |
|
Aug 12
17:17 UTC
|
NTRA
Natera
|
◎ Target | Mason Carrico ★★★☆☆ #2255 | Overweight | $305.00→ $350.00+14.8% |
|
Aug 12
17:17 UTC
|
NEM
Newmont
|
◎ Target | Tanya Jakusconek ★★★☆☆ #1903 | Outperform | $147.00→ $149.00+1.4% |
|
Aug 12
17:17 UTC
|
MPLX
Mplx
|
◎ Target | Robert Kad ★★★☆☆ #2151 | Equal Weight | $60.00→ $66.00+10.0% |
|
Aug 12
17:17 UTC
|
MLCO
Melco Resorts & Entertainment
|
◎ Target | Joseph Stauff ★★★☆☆ #1055 | Positive | $12.00→ $8.00-33.3% |
|
Aug 12
17:17 UTC
|
LENZ
LENZ Therapeutics
|
◎ Target | Biren Amin ★★☆☆☆ #2887 | Neutral | $12.00→ $7.00-41.7% |
|
Aug 12
17:17 UTC
|
LEG
Leggett & Platt
|
◎ Target | Peter Keith ★★★☆☆ #1436 | Neutral | $12.00→ $10.00-16.7% |
|
Aug 12
17:17 UTC
|
IMNM
Immunome
|
◎ Target | David Nierengarten ★★★☆☆ #2095 | Outperform | $31.00→ $35.00+12.9% |
|
Aug 12
17:17 UTC
|
HG
Hamilton Insurance Group
|
◎ Target | Tommy McJoynt not yet tracked | Outperform | $39.00→ $40.00+2.6% |
|
Aug 12
17:17 UTC
|
GPMT
Granite Point Mortgage Trust
|
◎ Target | Jade Rahmani ★★★☆☆ #1223 | Market Perform | $1.50→ $1.25-16.7% |
|
Aug 12
17:17 UTC
|
FLY
Firefly Aerospace
|
◎ Target | Mike Crawford ★★★☆☆ #1474 | Buy | $60.00→ $50.00-16.7% |
|
Aug 12
17:17 UTC
|
ETOR
eToro Group
|
◎ Target | Chris Allen not yet tracked | Market Perform | $45.00→ $35.00-22.2% |
|
Aug 12
17:17 UTC
|
DDI
DoubleDown Interactive
|
◎ Target | Josh Nichols ★★★☆☆ #1666 | Buy | $22.00→ $24.00+9.1% |
|
Aug 12
17:17 UTC
|
CRBG
Corebridge Financial
|
◎ Target | Paul Newsome ★★★☆☆ #1496 | Overweight | $36.00→ $38.00+5.6% |
|
Aug 12
17:17 UTC
|
COAG
Hemab Therapeutics
|
◎ Target | David Nierengarten ★★★☆☆ #2095 | Outperform | $55.00→ $64.00+16.4% |
|
Aug 12
17:17 UTC
|
CCAP
Crescent Capital BDC
|
◎ Target | Sean-Paul Adams ★★★★★ #34 | Neutral | $13.50→ $12.50-7.4% |
|
Aug 12
17:17 UTC
|
CAVA
CAVA Group
|
◎ Target | Margaret-May Binshtok not yet tracked | Outperform | $79.00→ $82.00+3.8% |
|
Aug 12
17:17 UTC
|
BCAX
Bicara Therapeutics
|
◎ Target | David Nierengarten ★★★☆☆ #2095 | Outperform | $30.00→ $33.00+10.0% |
|
Aug 12
17:17 UTC
|
AXP
American Express
|
◎ Target | Bill Carcache not yet tracked | Overweight | $396.00→ $405.00+2.3% |
|
Aug 12
17:17 UTC
|
AMRZ
Amrize
|
◎ Target | Trey Grooms ★★★☆☆ #1522 | Overweight | $65.00→ $54.00-16.9% |
|
Aug 12
16:17 UTC
|
WBI
WBI
|
◎ Target | Robert Kad ★★★☆☆ #2151 | Overweight | $38.00→ $43.00+13.2% |
|
Aug 12
16:17 UTC
|
VOR
Vor Biopharma
|
◎ Target | Martin Fan ★★★★☆ #878 | Neutral | $18.00→ $27.00+50.0% |
|
Aug 12
16:17 UTC
|
UDR
United Dominion Realty Trust
|
◎ Target | Adam Kramer ★★☆☆☆ #2294 | Equal Weight | $44.50→ $42.00-5.6% |
|
Aug 12
16:17 UTC
|
TRNO
Terreno Realty
|
◎ Target | Greg McGinniss ★★★☆☆ #1431 | Sec→ r Outperform | $68.00→ $72.00+5.9% |
|
Aug 12
16:17 UTC
|
TE
T1 Energy
|
◎ Target | Gregory Lewis ★★★☆☆ #1882 | Buy | $8.00→ $9.00+12.5% |
|
Aug 12
16:17 UTC
|
TARS
Tarsus Pharmaceuticals
|
◎ Target | Francois Brisebois ★★☆☆☆ #2862 | Outperform | $97.00→ $100.00+3.1% |
|
Aug 12
16:17 UTC
|
SUI
Sun Communities
|
◎ Target | Adam Kramer ★★☆☆☆ #2294 | Equal Weight | $135.00→ $126.00-6.7% |
|
Aug 12
16:17 UTC
|
STXS
Stereotaxis
|
◎ Target | Joshua Jennings not yet tracked | Buy | $5.00→ $3.00-40.0% |
|
Aug 12
16:17 UTC
|
SKIN
Beauty Health
|
◎ Target | Oliver Chen ★★★☆☆ #1286 | Hold | $1.00→ $0.90-10.0% |
|
Aug 12
16:17 UTC
|
SGMT
Sagimet Biosciences
|
◎ Target | Edward Nash ★★☆☆☆ #2737 | Buy | $49.00→ $56.00+14.3% |
An analyst rating change is when a Wall Street brokerage updates its recommendation on a stock — an upgrade (e.g. Hold → Buy), a downgrade (e.g. Buy → Sell), or a price-target revision (raising or lowering the expected share price). This page lists the most recent changes across U.S. markets.
Where we independently track the analyst, each change shows our own star rating and accuracy rank, computed from real historical price performance — not the brokerage's own marketing. That lets you judge whether the analyst behind a call has actually been right before.
The feed refreshes several times a day, so new upgrades, downgrades and price-target changes appear the same day they are published. Each row shows the date and time we recorded it.
No. A rating change is one analyst's opinion, not investment advice. Track records vary widely — which is exactly why we attach each analyst's independent accuracy. Always do your own research.